Modeling xenobiotic-induced autoimmunity using Collaborative Cross strains.
使用协作交叉菌株模拟外源性诱导的自身免疫。
基本信息
- 批准号:9912022
- 负责人:
- 金额:$ 26.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-03-01 至 2022-02-28
- 项目状态:已结题
- 来源:
- 关键词:AddressAllelesAnimal ModelAnimalsAsiansAutoantibodiesAutoimmune DiseasesAutoimmune ProcessAutoimmunityBiological MarkersBiological Response ModifiersChromosome MappingCluster AnalysisComplexComputer softwareDataDevelopmentDiagnosticDiseaseEnvironmental ExposureEuropeanEventExhibitsExposure toGenesGeneticGenetic HeterogeneityGenetic MarkersGenetic Predisposition to DiseaseGenetic VariationGenetic studyGenomeGenotypeGoalsHumanInbred MouseInbred Strains MiceInbreedingInflammasomeInflammationInflammation MediatorsInflammatoryInterferon Type IKidney DiseasesLaboratoriesLaboratory miceLinkMercuric chlorideMercuryModelingMolecularMouse StrainsMusPathogenesisPathologyPathway interactionsPhenotypePlayPopulationPopulation HeterogeneityQuantitative Trait LociRandomizedRecombinant Inbred StrainRecombinantsReproducibilityResearchResearch PersonnelResourcesRoleSNP arraySerumSeveritiesSeverity of illnessSilicon DioxideTestingVariantXenobioticscrystallinitydisease phenotypegenetic associationgenome-widegenomic locushuman diseaseimprovedinflammatory markerinsightnovelphenotypic dataresponsesystemic autoimmune diseasesystemic autoimmunitytherapeutic targettool
项目摘要
Autoimmunity is thought to result from a combination of genetics, environmental triggers, and stochastic events.
Although the role of environmental/xenobiotic agents in triggering autoimmunity is well established, it is unclear
if idiopathic and experimentally induced disease arise by common genetic, molecular and cellular pathways.
Genetic studies have suggested that idiopathic and xenobiotic-induced animal models of systemic autoimmunity
share common requirements as well as significant differences, such as the importance of the inflammasome and
type I interferons. The lack of genetic and phenotypic criteria for discriminating between idiopathic and
environmental/xenobiotic-induced systemic autoimmune disease is a critical barrier to our understanding of
autoimmunity in general. Inbred laboratory mouse strains have proven vital for autoimmune disease research
because the inbred genotype provides a genetically uniform animal for experimental purposes. However, the
restricted genetic heterogeneity among the common laboratory strains that is primarily derived from two original
Asian and European fancy mice, limits the diversity of common variants that are currently thought to play the
major role in complex diseases such as systemic autoimmunity. We propose that the Collaborative Cross (CC)
mouse panel is better suited to model the range of phenotypes in complex disease because it is the only
mammalian resource with genome-wide genetic variation randomized across a large, heterogeneous and
reproducible population and it incorporates the genomes of three strains of wild mice from different continents.
Consequently, CC mice strains provide a powerful tool to model environmental/xenobiotic-induced autoimmunity
in a genetically heterogeneous population. To test this, we will examine the response of CC strains to crystalline
silica and HgCl2. These two agents have been chosen because HgCl2 induces features of autoimmunity
(autoantibodies, kidney disease), but not overt disease in humans and mice, while crystalline silica induces
systemic autoimmune disease in both. We hypothesize that the genetic diversity of the CC panel of recombinant
inbred (RI) strains will allow us to show that exposure to HgCl2 and silica leads to different profiles of immune
mediators, inflammation, autoantibodies, and pathology which explain their disparate levels of disease severity.
Additionally, we argue that use of the CC RI strains will not only significantly improve our ability to identify genetic
loci, but to also determine specific genes and molecular pathways that discriminate HgCl2- and silica-induced
systemic autoimmune disease from each other as well as from idiopathic systemic autoimmunity. We will address
this in three aims. Specific aim 1: Analysis of baseline serum biomarkers in CC RI strains, Specific Aim 2:
Induction and analysis of xenobiotic-induced autoimmunity in CC RI mice, and Specific Aim 3: Genetic mapping
of xenobiotic-induced autoimmunity in CC RI mice. Successful completion of these studies should result in a
greater understanding of the underlying genetics and biomarkers of xenobiotic-induced systemic autoimmunity,
enhancing diagnostic capability, and identification of potential therapeutic targets.
自身免疫被认为是遗传学、环境诱因和随机事件共同作用的结果。
尽管环境/异源因子在触发自身免疫中的作用已得到充分证实,但尚不清楚。
如果特发性和实验诱发的疾病是由常见的遗传、分子和细胞途径引起的。
遗传学研究表明,特发性和异物诱导的系统性自身免疫动物模型
既有共同的要求,也有显著的差异,如炎症小结的重要性和
I型干扰素。缺乏区分特发性和特发性的遗传和表型标准
环境/异物诱导的全身性自身免疫性疾病是我们理解
自体免疫力一般。近亲繁殖的实验室小鼠品系已被证明对自身免疫性疾病研究至关重要
因为近亲交配的基因为实验目的提供了一致的遗传基因。然而,
常见实验室菌株之间的限制性遗传异质性,主要来自两个原始菌株
亚洲和欧洲的花哨老鼠,限制了目前被认为发挥作用的常见变体的多样性
在系统性自身免疫等复杂疾病中发挥重要作用。我们建议协作十字(CC)
鼠标面板更适合于对复杂疾病的表型范围进行建模,因为它是唯一
具有全基因组遗传变异的哺乳动物资源,随机分布在一个巨大的、异质的和
它包含了来自不同大陆的三种野鼠品系的基因组。
因此,CC小鼠品系为模拟环境/异种生物诱导的自身免疫提供了有力的工具。
在一个遗传异质性的种群中。为了测试这一点,我们将检查CC菌株对晶状体的反应
二氧化硅和氯化汞。之所以选择这两种药物是因为HgCl2诱导了自身免疫的特征
(自身抗体,肾脏疾病),但在人类和小鼠中不是显性疾病,而结晶二氧化硅导致
两者都有系统性自身免疫性疾病。我们假设重组人CC组的遗传多样性
近交系(RI)菌株将允许我们表明,暴露在HgCl2和二氧化硅中会导致不同的免疫模式
介质、炎症、自身抗体和病理,解释了它们不同的疾病严重程度。
此外,我们认为,使用CC RI菌株不仅将显著提高我们识别基因的能力
但也要确定区分HgCl2和二氧化硅诱导的特定基因和分子途径
系统性自身免疫性疾病相互之间以及特发性系统性自身免疫性疾病。我们将解决
这有三个目标。具体目标1:分析CC RI菌株的基线血清生物标记物;
异种生物诱导CC-RI小鼠自身免疫的诱导和分析及其特异性目标3:基因定位
异种生物诱导CC RI小鼠自身免疫的研究。成功完成这些研究应该会导致
更好地了解异种生物诱导的系统性自身免疫的潜在遗传学和生物标记物,
提高诊断能力,识别潜在的治疗靶点。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth Michael Pollard其他文献
Kenneth Michael Pollard的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth Michael Pollard', 18)}}的其他基金
Collaborative Cross Strains as Models of Systemic Autoimmunity
协作交叉菌株作为系统性自身免疫模型
- 批准号:
10730346 - 财政年份:2023
- 资助金额:
$ 26.63万 - 项目类别:
Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity
外源性自身免疫的早期致病步骤
- 批准号:
10367852 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别:
Early Pathogenic Steps in Xenobiotic-Induced Autoimmunity
外源性自身免疫的早期致病步骤
- 批准号:
10579269 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别:
Do Xenobiotics Exacerbate Idiopathic Autoimmunity?
异生素会加剧特发性自身免疫吗?
- 批准号:
9506204 - 财政年份:2018
- 资助金额:
$ 26.63万 - 项目类别:
The effect of age on xenobiotic-induced autoimmunity
年龄对异生素诱导的自身免疫的影响
- 批准号:
10002226 - 财政年份:2018
- 资助金额:
$ 26.63万 - 项目类别:
Do Xenobiotics Exacerbate Idiopathic Autoimmunity?
异生素会加剧特发性自身免疫吗?
- 批准号:
9762107 - 财政年份:2018
- 资助金额:
$ 26.63万 - 项目类别:
相似海外基金
Linkage of HIV amino acid variants to protective host alleles at CHD1L and HLA class I loci in an African population
非洲人群中 HIV 氨基酸变异与 CHD1L 和 HLA I 类基因座的保护性宿主等位基因的关联
- 批准号:
502556 - 财政年份:2024
- 资助金额:
$ 26.63万 - 项目类别:
Olfactory Epithelium Responses to Human APOE Alleles
嗅觉上皮对人类 APOE 等位基因的反应
- 批准号:
10659303 - 财政年份:2023
- 资助金额:
$ 26.63万 - 项目类别:
Deeply analyzing MHC class I-restricted peptide presentation mechanistics across alleles, pathways, and disease coupled with TCR discovery/characterization
深入分析跨等位基因、通路和疾病的 MHC I 类限制性肽呈递机制以及 TCR 发现/表征
- 批准号:
10674405 - 财政年份:2023
- 资助金额:
$ 26.63万 - 项目类别:
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
具有 HLA 匹配等位基因的现成肿瘤细胞疫苗,用于晚期实体瘤的个性化治疗
- 批准号:
10758772 - 财政年份:2023
- 资助金额:
$ 26.63万 - 项目类别:
Identifying genetic variants that modify the effect size of ApoE alleles on late-onset Alzheimer's disease risk
识别改变 ApoE 等位基因对迟发性阿尔茨海默病风险影响大小的遗传变异
- 批准号:
10676499 - 财政年份:2023
- 资助金额:
$ 26.63万 - 项目类别:
New statistical approaches to mapping the functional impact of HLA alleles in multimodal complex disease datasets
绘制多模式复杂疾病数据集中 HLA 等位基因功能影响的新统计方法
- 批准号:
2748611 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别:
Studentship
Genome and epigenome editing of induced pluripotent stem cells for investigating osteoarthritis risk alleles
诱导多能干细胞的基因组和表观基因组编辑用于研究骨关节炎风险等位基因
- 批准号:
10532032 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别:
Recessive lethal alleles linked to seed abortion and their effect on fruit development in blueberries
与种子败育相关的隐性致死等位基因及其对蓝莓果实发育的影响
- 批准号:
22K05630 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigating the Effect of APOE Alleles on Neuro-Immunity of Human Brain Borders in Normal Aging and Alzheimer's Disease Using Single-Cell Multi-Omics and In Vitro Organoids
使用单细胞多组学和体外类器官研究 APOE 等位基因对正常衰老和阿尔茨海默病中人脑边界神经免疫的影响
- 批准号:
10525070 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别:
Leveraging the Evolutionary History to Improve Identification of Trait-Associated Alleles and Risk Stratification Models in Native Hawaiians
利用进化历史来改进夏威夷原住民性状相关等位基因的识别和风险分层模型
- 批准号:
10689017 - 财政年份:2022
- 资助金额:
$ 26.63万 - 项目类别: